AAAAAA

   
Results: 1-11 |
Results: 11
G-CSF ADMINISTRATION FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT IN LYMPHOID MALIGNANCIES - EVIDENCE FOR CLINICAL BENEFITS AND REDUCTION OF TREATMENT COSTS
Authors: TARELLA C CASTELLINO C LOCATELLI F CARACCIOLO D CORRADINI P FALDA M NOVARINO A TASSI V PILERI A
Citation: C. Tarella et al., G-CSF ADMINISTRATION FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT IN LYMPHOID MALIGNANCIES - EVIDENCE FOR CLINICAL BENEFITS AND REDUCTION OF TREATMENT COSTS, Bone marrow transplantation, 21(4), 1998, pp. 401-407
A SINGLE-STEP DENSITY GRADIENT SEPARATION FOR LARGE-SCALE ENRICHMENT OF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS COLLECTED FOR AUTOTRANSPLANTATION
Authors: FERRERO D TARELLA C CHERASCO C BONDESAN P OMEDE P RAVAGLIA R CARACCIOLO D CASTELLINO C PILERI A
Citation: D. Ferrero et al., A SINGLE-STEP DENSITY GRADIENT SEPARATION FOR LARGE-SCALE ENRICHMENT OF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS COLLECTED FOR AUTOTRANSPLANTATION, Bone marrow transplantation, 21(4), 1998, pp. 409-413
OVERALL TOXICITY AND LONG-TERM OUTCOME IN 120 AUTOTRANSPLANT PROCEDURES WITH MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: TARELLA C CARACCIOLO D CORRADINI P CASTELLINO C ZALLIO F TASSI W ROSSI G MASSAIA M FERRERO D BOCCADORO M PILERI A
Citation: C. Tarella et al., OVERALL TOXICITY AND LONG-TERM OUTCOME IN 120 AUTOTRANSPLANT PROCEDURES WITH MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Bone marrow transplantation, 21, 1998, pp. 690-690
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME
Authors: TARELLA C CASTELLINO C CHERASCO C BONDESAN P GIARETTA F CORRADINI P CARACCIOLO D GAVAROTTI P PILERI A
Citation: C. Tarella et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME, British Journal of Haematology, 99(1), 1997, pp. 41-46
FEASIBILITY AND EFFICACY OF NEGATIVE IN-VITRO PURGING ON MOBILIZED HEMATOPOIETIC PROGENITORS IN FOLLICULAR AND MANTLE-CELL LYMPHOMA PATIENTS TREATED WITH THE HDS REGIMEN
Authors: TARELLA C FERRERO D CORRADINI P ASTOLFI M BONDESAN P CARACCIOLO D CASTELLINO C CHERASCO C GIARETTA F MASSAIA M OMEDE P PILERI A
Citation: C. Tarella et al., FEASIBILITY AND EFFICACY OF NEGATIVE IN-VITRO PURGING ON MOBILIZED HEMATOPOIETIC PROGENITORS IN FOLLICULAR AND MANTLE-CELL LYMPHOMA PATIENTS TREATED WITH THE HDS REGIMEN, Blood, 90(10), 1997, pp. 954-954
HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY AS SALVAGE TREATMENT IN 33 PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA
Authors: TARELLA C CARACCIOLO D GAVAROTTI P CORRADINI P ZALLIO F CASTELLINO C PILERI A
Citation: C. Tarella et al., HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY AS SALVAGE TREATMENT IN 33 PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 3881-3881
HDS CHEMOTHERAPY AS UPFRONT TREATMENT IN 35 PATIENTS WITH INDOLENT LYMPHOMA INDUCES A HIGH-RATE OF DURABLE CLINICAL AND MOLECULAR REMISSION
Authors: TARELLA C CORRADINI P CARACCIOLO D ASTOLFI M CASTELLINO C GAVAROTTI P PILERI A
Citation: C. Tarella et al., HDS CHEMOTHERAPY AS UPFRONT TREATMENT IN 35 PATIENTS WITH INDOLENT LYMPHOMA INDUCES A HIGH-RATE OF DURABLE CLINICAL AND MOLECULAR REMISSION, Blood, 88(10), 1996, pp. 471-471
HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS
Authors: TARELLA C GAVAROTTI P CARACCIOLO D CORRADINI P CHERASCO C CASTELLINO C GALLO E PILERI A
Citation: C. Tarella et al., HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS, Annals of oncology, 6, 1995, pp. 3-8
BOTH EARLY AND COMMITTED HEMATOPOIETIC PROGENITORS ARE MORE FREQUENT IN PERIPHERAL-BLOOD THAN IN BONE-MARROW DURING MOBILIZATION INDUCED BYHIGH-DOSE CHEMOTHERAPY PLUS G-CSF
Authors: TARELLA C BENEDETTI G CARACCIOLO D CASTELLINO C CHERASCO C BONDESAN P OMEDE P RUGGIERI D GIANNI AM PILERI A
Citation: C. Tarella et al., BOTH EARLY AND COMMITTED HEMATOPOIETIC PROGENITORS ARE MORE FREQUENT IN PERIPHERAL-BLOOD THAN IN BONE-MARROW DURING MOBILIZATION INDUCED BYHIGH-DOSE CHEMOTHERAPY PLUS G-CSF, British Journal of Haematology, 91(3), 1995, pp. 535-543
FEASIBILITY AND TOXICITY OF HIGH-DOSE CHEMOTHERAPY WITH GROWTH-FACTORAND CIRCULATING PROGENITOR SUPPORT - THE EXPERIENCE IN 111 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS
Authors: TARELLA C CARACCIOLO D GAVAROTTI P CORRADINI P CASTELLINO C CHERASCO C BIANCHI A MASSAIA M PALUMBO A BOCCADORO M PILERI A
Citation: C. Tarella et al., FEASIBILITY AND TOXICITY OF HIGH-DOSE CHEMOTHERAPY WITH GROWTH-FACTORAND CIRCULATING PROGENITOR SUPPORT - THE EXPERIENCE IN 111 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS, Blood, 86(10), 1995, pp. 3857-3857
CIRCULATING PROGENITORS IN LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND G-CSF
Authors: TARELLA C CARACCIOLO D GAVAROTTI P BENEDETTI G BONDESAN P CASTELLINO C CHERASCO C PILERI A
Citation: C. Tarella et al., CIRCULATING PROGENITORS IN LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND G-CSF, Blood, 82(10), 1993, pp. 10000654-10000654
Risultati: 1-11 |